Skip to main content

. 1957 Jun;11(2):287–295. doi: 10.1038/bjc.1957.37

The Antigenic Composition of Mouse Ascites Tumour Cells Using In Vitro and Gel-diffusion Techniques

G C Easty, E J Ambrose

PMCID: PMC2073735 PMID: 13460153

287

Images in this article

Figs. 1-3
on p.288-1

Figs. 12-16
on p.288-7

Figs. 8-11
on p.288-5

Figs. 4-7
on p.288-3

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

KALFAYAN B., KIDD J. G. Structural changes produced in Brown-Pearce carcinoma cells by means of a specific antibody and complement. J Exp Med. 1953 Jan;97(1):145–162. doi: 10.1084/jem.97.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
MILLER D. G., HSU T. C. The action of cytotoxic antisera on the HeLa strain of human carcinoma. Cancer Res. 1956 May;16(4):306–312. [PubMed] [Google Scholar]
NUNGESTER W. J., FISHER H. The inactivation in vivo of mouse lymphosarcoma 6C3HED by antibodies produced in a foreign host species. Cancer Res. 1954 May;14(4):284–288. [PubMed] [Google Scholar]
PRESSMAN D., KORNGOLD L. The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies. Cancer. 1953 May;6(3):619–623. doi: 10.1002/1097-0142(195305)6:3<619::aid-cncr2820060319>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
SCHREK R., PRESTON F. W. Toxicity of homologous immune serum to a transplantable tumor: studies using phase microscopy and cinemicrography. J Natl Cancer Inst. 1956 Feb;16(4):1021–1045. [PubMed] [Google Scholar]

ACTIONS

RESOURCES